Transaction in OwnShs-Replace

GlaxoSmithKline PLC
11 August 2004



Please note this is an amendment to an earlier announcement released under RNS
8823B.  The number of shares the Company has in issue excluding Treasury shares
is 5,901,326,401 and not 5,934,044,401 as previously stated.


                              GlaxoSmithKline PLC


GlaxoSmithKline plc (the "Company") announces that in accordance with the
authority granted by shareholders at the Company's Annual General Meeting on 17
May 2004 it purchased 1,000,000 of it's Ordinary shares of 25 pence each ("
shares") on 11th August 2004 at a price of 1065.62 pence per share.


The Company intends to hold these shares in Treasury.


Following the purchase of these shares, the Company holds 32,718,000 of it's
shares in Treasury and has 5,901,326,401 shares in issue (excluding Treasury
shares).


This announcement does not constitute, or form part of, an offer or any
solicitation of an offer to purchase or subscribe for securities in any
jurisdiction.




                      This information is provided by RNS
            The company news service from the London Stock Exchange